Insider filing · BGNE
Chan Henry Lee
SVP, General Counsel
profile →
Chan Henry Lee sold $285K of BeiGene (BGNE)
Executed Sep 30 2024, disclosed Oct 2 2024, 2 days later.
Value, as filed
$285K
1,202 sh × $237.10
Executed
Sep 30 2024
the trade date, as filed
Disclosed
Oct 2 2024
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CLChan Henry Lee (SVP, General Counsel) filed 15 Form 4 reports in the trailing twelve months (0 purchases, 15 sales), most often in BeOne Medicines AG (ONC). The largest single filing was $3.7M of ONC (10,671 sh across 4 lots, as filed), executed Oct 8 2025.
The name
BGNE
BGNE
BGNE · 23 filings in 24 months
ticker →
Insider filings, newest first→
View the original filing at www.sec.gov→
Other filings by Chan Henry Lee in BGNE
BGNESALE
BeiGene, Ltd.
$331K1,205 sh × $275.00
Exec Feb 27 2025
Filed Mar 3 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. $284K
1,102 sh across 2 lots
Exec Feb 21 2025
Filed Feb 25 2025 · 5:30 PM ET